COVAX Registry: 1519 patients w/ 51% IA, 45% CsDMARDs, 36% bioDMARDs, 31% GCs; vaccinated with Pfizer, AZ or Moderna. Overall, very reassuring safety profile. 5% flares. Efficacy to trigger AB response needs to be further assessed. @pedrommcmachado #LB0004 @Rheumnow #EULAR2021 https://t.co/1dSfOJALzf